ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 25 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,890 | -40.6% | 52,354 | 0.0% | 0.00% | – |
| Q1 2023 | $18,324 | -17.8% | 52,354 | -50.0% | 0.00% | – |
| Q4 2022 | $22,302 | +23.9% | 104,708 | +100.0% | 0.00% | – |
| Q3 2022 | $18,000 | -74.3% | 52,354 | 0.0% | 0.00% | – |
| Q2 2022 | $70,000 | -33.3% | 52,354 | 0.0% | 0.00% | – |
| Q1 2022 | $105,000 | -22.2% | 52,354 | +4.4% | 0.00% | – |
| Q4 2021 | $135,000 | -37.2% | 50,154 | 0.0% | 0.00% | – |
| Q3 2021 | $215,000 | +72.0% | 50,154 | +2.5% | 0.00% | – |
| Q2 2021 | $125,000 | – | 48,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 77,694 | $27,000 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 36,461 | $12,000 | 0.00% |
| ROYAL BANK OF CANADA | 25 | $0 | 0.00% |
| VANGUARD GROUP INC | 616,855 | $216,000 | 0.00% |
| Private Advisor Group, LLC | 21,400 | $7,000 | 0.00% |
| UBS Group AG | 35,517 | $12,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 58,389 | $20,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 8,321 | $3,000 | 0.00% |
| FMR LLC | 7 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,005 | $0 | 0.00% |